The value of serology testing to manage SARS-CoV-2 infections

摘要

The figures presented in the World Health Organization’s latest report on the current status of the coronavirus disease 2019 (COVID-19) pandemic and the COVID-19 dashboard of the Johns Hopkins University of Medicine are quite similar: respectively, 6,416,828 and 6,656,827 cases worldwide, and 382 867 and 391 571 deaths [1, 2]. The origin of the pandemic is believed to have been a wet market in Wuhan, China, where the new strain of coronavirus (severe acute respiratory syndrome coronavirus 2, SARS-CoV-2) was initially extracted from several patients’ lower respiratory tract samples in December 2019 [3]. These patients presented with symptoms of severe pneumonia, including fever, fatigue, dry cough and respiratory distress in 29% of cases .